| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Advertising > Advertising: Relationships vs Business Decisions |
|
Advice You - Advertising: Relationships vs Business Decisions
Successful businesses know the importance of building and maintaining good working relationships, whether it is with partne According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product rs, employees, business or trade organizations, the government, media representatives, vendors, consumers, or the community ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in at large. A business must carefully balance the benefits of these interpersonal relationships and should never allow these lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. relationships to blind their judgment especially when it relates to what is in the best interest of the business's continue here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe success and growth Buying advertising media based on interpersonal relationships is a common mistake made by many small b d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro sinesses. This strategy throws the business's strategic marketing plan into the winds of chance in exchange for the warm a ucts have become life saving products for the pharmaceutical companies who doesnt have many innovative molecules in their product pipeline and have been inc d fuzzy feelings that come with doing business among friends. However, when the smoke clears the business has made costly easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi dvertising expenditures with little or no results and the long term negative effects may not readily be seen. Simply, the nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically arketing / advertising expenditures have been made, the budget may or may not be busted, and the results may be none to lit and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ le measurable penetration into the business's target demographic market segment. Is buying media from a friend in the busi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ess always bad? No, however in order to choose the most effective media channels a business must first consider the audien ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ce or customer it is trying to reach. Developing a strong sense of the target demographics' buying and shopping patterns, dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod nterests and hobbies, entertainment and media choices for example will lend itself a tremendous benefit to making informed cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin edia buying choices. Once the advertising business has developed a strong sense of what media channels may prove to be the tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen most effective it should try each a little at a time carefully tracking the results of each. Once this is complete the bus t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ness will be able to make an educated decision on where to invest its marketing dollars, prioritizing expenditures into the ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust mediums that have proven results for the business. It is true that strong interpersonal relationships skills and the abili y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products y to develop and maintain good working relationships with a variety of people, businesses, and other organizations are impe . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ative in today's business environments. However, the importance of a well designed and implemented strategic marketing pla elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip can not be understated and is paramount to the business's development and longevity never taking second seat to friendship tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:A Logo Isn't A Tattoo! Why Your Personal Tastes Have Nothing To Do With Your Logo
|